CD4 and acute lymphoblastic leukemia: These CAR-iCD4+ T cells were co-cultured with the CD19+ acute lymphoblastic leukemia cell line NALM6 for a short-term (3-h) killing assay, as shown in Fig. 2E. CAR-transduced primary CD4+ and CD8+ T cells from different donors served as controls.